InvestorsHub Logo
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: Protector post# 228605

Monday, 08/03/2015 6:47:33 PM

Monday, August 03, 2015 6:47:33 PM

Post# of 346191
I like what your saying CP but a realistic buyout after Bavituximab approval would probably be to the tune of the ABBV PCYC aquisition 20B. Maybe by this time next year?

If trial halted on second look in, Yervoy trial Bavi doubles efficacy and we have two new late stage open label trials in breast and frontline showing positive preliminary ORR numbers?

Yes a lot of what if but definitely possible this time next year 20b deal.

But I believe we see a partner soon after first look with 1b upfront and milestones to the tune of billions on approval for each indication.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News